UAE enforces up to AED 100,000 fine and jail for intentionally spreading communicable diseases

Deliberately spreading a communicable disease in the UAE now carries imprisonment and fines up to AED 100,000 under federal law. The penalty structure places direct compliance obligations on healthcare operators, employers, and individuals across all seven emirates.

The provisions fall under Federal Decree-Law No. 14 of 2014 on Combating Communicable Diseases, reinforced by cabinet resolutions that expanded the list of notifiable conditions and tightened reporting requirements. MOHAP is the primary federal enforcement authority. DHA and Abu Dhabi's Department of Health (DOH) act as local enforcers within their respective jurisdictions.

Penalty structure and reporting thresholds

The law targets individuals who knowingly transmit or facilitate the spread of a communicable disease. The penalty framework operates on a sliding scale:

• Failure to report a notifiable disease: fines starting at AED 10,000
• Intentional transmission: imprisonment of up to five years and fines reaching AED 100,000
• Transmission resulting in death or permanent disability: escalated penalties under the UAE Penal Code
• Institutional non-compliance with reporting mandates: fines up to AED 200,000 and potential license suspension

Hospitals and clinics must report confirmed or suspected communicable disease cases to the relevant health authority within 24 hours.

Who this affects most

COOs and compliance officers at UAE healthcare facilities face a clear operational requirement: disease surveillance protocols must be current, staff must be trained on mandatory notification procedures, and reporting channels to MOHAP, DHA, or DOH must be tested and functional. The 24-hour reporting window leaves no room for administrative delay.

HR directors face a workforce dimension. Employers in healthcare settings must ensure that staff with confirmed communicable diseases are isolated per protocol and that workplace transmission prevention measures meet regulatory standards. The law does not distinguish between clinical and non-clinical staff.

For medical directors, the provision raises questions about clinical documentation. A treating physician who identifies a communicable disease and fails to trigger the facility's reporting chain could expose both the individual and the institution to penalties. MOHAP's notifiable disease list includes over 60 conditions, from tuberculosis and hepatitis to seasonal influenza and measles.

Where UAE regulators are heading

The enforcement emphasis follows the UAE's post-pandemic overhaul of public health governance. Since 2020, MOHAP has invested heavily in disease surveillance infrastructure, including the National Disease Surveillance System that connects hospitals, primary care clinics, and laboratories. The system processes data from more than 4,000 licensed healthcare facilities nationwide.

DHA issued updated communicable disease guidelines for Dubai facilities in late 2025, requiring electronic reporting integration with the authority's health information exchange platform. DOH in Abu Dhabi has maintained similar requirements through its Malaffi health information exchange, which connects all licensed providers in the emirate.

Operators should treat this as a compliance audit trigger. Facilities that have not reviewed their communicable disease protocols since the pandemic-era updates risk gaps that the law now penalizes with criminal consequences, not administrative ones. UAE regulators now treat disease containment as a public safety matter with criminal liability attached.